Author

admin

Browsing

Investor Insight InMed is a pharmaceutical drug development company advancing proprietary small-molecule drugs in Alzheimer’s and ophthalmology, backed by a revenue-generating manufacturing subsidiary. The company is an undervalued opportunity with cash exceeding market capitalization and multiple upcoming catalysts. Overview InMed Pharmaceuticals (NASDAQ:INM) is a biopharmaceutical company with a differentiated business…

In this video, Mary Ellen spotlights the areas driving market momentum following Taiwan Semiconductor’s record-breaking earnings report. She analyzes continued strength in semiconductors, utilities, industrials, and AI-driven sectors, plus highlights new leadership in robotics and innovation-focused ETFs like ARK. From there, Mary Ellen breaks down weakness in health care and…

Perth, Australia (ABN Newswire) – Locksley Resources Ltd (ASX:LKY,OTC:LKYRF) (FRA:X5L) (OTCMKTS:LKYRF) announced it has formalised a research collaboration with Columbia University, one of the United States’ premier institutions in sustainable mineral processing, to advance next-generation recovery and separation of REEs and other energy and technology critical metals from geologic resources…